Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

December 19, 2023

Study Completion Date

November 30, 2027

Conditions
HIV-1 Infection
Interventions
DRUG

ISL

Capsules administered orally without regard to food

DRUG

LEN

Tablets administered orally without regard to food

DRUG

B/F/TAF

Tablets administered orally without regard to food

DRUG

ISL/LEN FDC

Tablets administered orally without regard to food

Trial Locations (44)

10461

Jacobi Medical Center, The Bronx

11355

New York-Presbyterian Queens, Flushing

19104

Penn Medicine: Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania, Philadelphia

19107

Philadelphia FIGHT Community Health Centers, Philadelphia

20017

Washington Health Institute, Washington D.C.

20037

The George Washington University Medical Faculty Associates Inc., Washington D.C.

27599

NC TraCS Institute - CTRC: University of North Carolina at Chapel Hill, Chapel Hill

30033

Metro Infectious Disease Consultants, Decatur

30308

Emory University Hospital Midtown Infectious Disease Clinic, Atlanta

30309

Atlanta ID Group, PC, Atlanta

31401

Chatham County Health Department, Savannah

32803

Orlando Immunology Center, Orlando

33016

Floridian Clinical Research, Miami Lakes

33136

Schiff Center for Liver Diseases/University of Miami, Miami

33316

CAN Community Health Care, Inc., Fort Lauderdale

33462

JEM Research Institute, Lake Worth

34982

Midway Immunology and Research Center, Ft. Pierce

46202

Indiana CTSI Clinical Research Center, Indianapolis

48072

Be Well Medical Center, Berkley

55112

Hennepin Healthcare HCMC, New Brighton

60613

Howard Brown Health Center, Chicago

60657

Northstar Healthcare, Chicago

63139

Southampton Healthcare, Inc., St Louis

75208

AIDS Arms Inc, Dallas

75246

North Texas Infectious Diseases Consultants, P.A., Dallas

77098

The Crofoot Research Center, INC, Houston

78705

Central Texas Clinical Research, LLC, Austin

80204

Public Health Institute at Denver Health, Denver

80246

Vivent Health, Denver

87505

AXCES Research Group, Santa Fe

89104

Huntridge Family Clinic, Las Vegas

90036

Ruane Clinical Research Group, Inc, Los Angeles

90069

Mills Clinical Research, Los Angeles

90211

Pacific Oaks Medical Group, Beverly Hills

92262

BIOS Clinical Research, Palm Springs

92663

Hoag Medical Group - Newport Beach, Newport Beach

94102

Optimus Medical Group, San Francisco

96813

John A. Burns School of Medicine, University of Hawaii Clinics at Kaka'ako, Honolulu

98104

Peter Shalit, M.D., Seattle

98405

Community Health Care, Tacoma

99202

MultiCare Rockwood Main Clinic, Spokane

02118

Boston Medical Center, Boston

02129

AccessHealth MA, Boston

08844

ID Care, Hillsborough

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Gilead Sciences

INDUSTRY